Plant Natural Products
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phytothérapie Et Polyphénols Naturels
REPUBLIQUE ALGERIENNE DEMOCRATIQUE ET POPULAIRE Ministère de l’Enseignement Supérieur et de la Recherche Scientifique Université Abdelhamid Ibn Badis Mostaganem Faculté Des Sciences De La Nature Et De La Vie Filière : Sciences Biologiques Spécialité : Microbiologie Appliquée Option : Interactions Micro- organismes, Hôtes et Environnements THÉSE PRESENTEE POUR L’OBTENTION DU DIPLOME DE DOCTORAT 3ème cycle LMD Par Mme. BENSLIMANE Sabria Contribution à l’étude de l’effet des extraits bruts des écorces du fruit de Punica granatum et des graines de Cuminum cyminum contre les biofilms à l’origine des infections bucco- dentaires. Soutenue le 18/01/2021 devant le jury: Président DJIBAOUI Rachid Pr Université de Mostaganem Directrice de thèse REBAI Ouafa MCA Université de Mostaganem Examinateur MEKHALDI Abdelkader Pr Université de Mostaganem Examinateur AIT SAADA Djamel MCA Université de Mostaganem Examinateur BEKADA Ahmed Med Ali Pr Centre Universitaire de Tissemsilet Année universitaire : 2020 -2021 Dédicaces Tout d’abord je tiens à dédier ce travail à la mémoire de ceux qui me sont chers mais qui ne font plus parti de ce monde, mon grand père Vladimir qui aurait été si fière de moi, mes grands parents paternel, ainsi que mon oncle parti si tôt, que dieu leur accorde sa miséricorde. À mes chers parents, pour tous leurs aides, leurs appuis, leurs dévouements, leurs sacrifices et leurs encouragements durant toutes mes années d’études. À ma très chère grand-mère Maria, qui m’a toujours soutenu et encouragé à poursuivre mes études, et pour tout ce qu’elle a fait pour moi depuis ma petite enfance. À mon très cher mari qui m’a toujours soutenu, encouragé et réconforté dans les moments les plus durs, merci pour ta compréhension et ton aide. -
(12) United States Patent (10) Patent No.: US 7,919,636 B2 Seeram Et Al
USOO7919636B2 (12) United States Patent (10) Patent No.: US 7,919,636 B2 Seeram et al. (45) Date of Patent: Apr. 5, 2011 (54) PURIFICATIONS OF POMEGRANATE Aviram, M., et al., “Pomegranate juice consumption inhibits serum ELLAGTANNINS AND THEIR USES angiotensin converting enzyme activity and reduces systolic blood THEREOF pressure.” (2001) Atherosclerosis, 158: 195-198. Cerda, B., et al., “Evaluation of bioavailability and metabolism in the (75) Inventors: Navindra P. Seeram, Los Angeles, CA rat of punicalagin, an antioxidant polyphenol from pomegranate juice.” (2003) Eur, J. Nutr., 42:18-28. (US); David Heber, Los Angeles, CA Cerda, B., et al., “Repeated oral administration of high doses of the (US) pomegranate elagitannin punicalaginto rats for 37 days is not toxic.” (2003) J. Agric. Food Chem. 51:3493-3501. (73) Assignee: The Regents of the University of Doig, A., et al., “Isolation and structure elucidation of punicalagin, a California, Oakland, CA (US) toxic hydrolysable tannin, from Terminalia oblongata.” (1990) J. Chem. Soc. Perkin Trans. I, 2317-2321. (*) Notice: Subject to any disclaimer, the term of this El-Toumy, S., et al., “Two ellagitannins from Punica granatum patent is extended or adjusted under 35 heartwood.” (2002) Phytochemistry, 61:971-974. U.S.C. 154(b) by 248 days. Filippich, L., et al., “Hepatotoxic and nephrotoxic principles in Terminalia oblongata.” (1991) Research in Veterinary Science, (21) Appl. No.: 12/143,657 50:17O-177. Gil, M., et al., “Antioxidant activity of pomegranate juice and its (22) Filed: Jun. 20, 2008 relationship with phenolic composition and processing.” (2000) J. Agric. Food Chem., 48:4581-4589. -
Pomegranate Peel Extract Activities As Antioxidant and Antibiofilm Against Bacteria Isolated from Caries and Supragingival Plaque
Volume 13, Number 3, September 2020 ISSN 1995-6673 JJBS Pages 403 - 412 Jordan Journal of Biological Sciences Pomegranate Peel Extract Activities as Antioxidant and Antibiofilm against Bacteria Isolated from Caries and Supragingival Plaque Sabria Benslimane, Ouafa Rebai*, Rachid Djibaoui, and Abed Arabi Laboratory of Microbiology and Vegetal Biology, Faculty of Natural Sciences and Life, University of Mostaganem, Algeria Received: October 5, 2019; Revised: November 20, 2019; Accepted: November 22, 2019 Abstract The present study aimed to extract polyphenols from pomegranate (Punica granatum L.) peel extract (PPE) by maceration using three different solvants: acetone 70%, ethanol 70% and methanol 70% (v/v). The antioxidant capacity potential was determined by scavenging activity of free radicals (DPPH) and ferric reducing power (FRAP) assays. The antimicrobial activity of PPE was evaluated against six oral pathogens isolated from dental caries and supragingival plaque (Streptococcus mutans, Enterococcus faecalis, Gemella morbillorum, Staphylococcus epidermis, Enterococcus bugandensis and Klebsiella oxytoca). The highest total phenolic and flavonoid contents were obtained with ethanolic PPE (204.67 ± 15.26 26 mg gallic acid equivalents (GAE)/g dry weight (DW), 67.67 ± 1.53 mg quercetin equivalent (QE)/g DW respectively). The highest proanthocyanidin content was observed with acetonic extract (220 ± 17.32 mg catechin equivalent (CE)/g DW). The phenolic profile of ethanolic PPE was determined by HPLC analysis; peduncalagin, punigluconin and punicalagin as a predominant ellagitannin have been identified. The highest scavenging activity (87.37 ± 1.36%) was exhibited by ethanolic PPE with the lowest IC50 value (220 ± 14µg/ml) for DPPH, whereas the highest reducing power assay was observed with acetonic PPE with a value of 1.48 at 700 nm. -
Pomegranate (Punica Granatum)
Functional Foods in Health and Disease 2016; 6(12):769-787 Page 769 of 787 Research Article Open Access Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics Veljko Veljkovic1,2, Sanja Glisic2, Vladimir Perovic2, Nevena Veljkovic2, Garth L Nicolson3 1Biomed Protection, Galveston, TX, USA; 2Center for Multidisciplinary Research, University of Belgrade, Institute of Nuclear Sciences VINCA, P.O. Box 522, 11001 Belgrade, Serbia; 3Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Corresponding author: Garth L Nicolson, PhD, MD (H), Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Submission Date: October 3, 2016, Accepted Date: December 18, 2016, Publication Date: December 30, 2016 Citation: Veljkovic V.V., Glisic S., Perovic V., Veljkovic N., Nicolson G.L.. Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics. Functional Foods in Health and Disease 2016; 6(12):769-787 ABSTRACT Background: Numerous in vitro and in vivo studies, in addition to clinical data, demonstrate that pomegranate juice can prevent or slow-down the progression of some types of cancers. Despite the well-documented effect of pomegranate ingredients on neoplastic changes, the molecular mechanism(s) underlying this phenomenon remains elusive. Methods: For the study of pomegranate ingredients the electron-ion interaction potential (EIIP) and the average quasi valence number (AQVN) were used. These molecular descriptors can be used to describe the long-range intermolecular interactions in biological systems and can identify substances with strong electron-acceptor properties. -
Functional Diversity of Genes for the Biosynthesis of Paeoniflorin and Its Derivatives in Paeonia
Int. J. Mol. Sci. 2013, 14, 18502-18519; doi:10.3390/ijms140918502 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Functional Diversity of Genes for the Biosynthesis of Paeoniflorin and Its Derivatives in Paeonia Yuan Yuan 1, Jun Yu 2, Chao Jiang 1, Minhui Li 1, Shufang Lin 1, Xumin Wang 2,* and Luqi Huang 1,* 1 National Resource Center for Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing 100700, China; E-Mails: [email protected] (Y.Y.); [email protected] (C.J.); [email protected] (M.L.); [email protected] (S.L.) 2 CAS Key Laboratory of Genome Sciences and Information, Beijing 100029, China; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mails: [email protected] (X.W.); [email protected] (L.H.); Tel.: +86-10-8299-5400 (X.W.); +86-10-8404-4340 (L.H.); Fax: +86-10-8299-5401 (X.W.); +86-10-8402-7175 (L.H.). Received: 18 June 2013; in revised form: 9 August 2013 / Accepted: 19 August 2013 / Published: 9 September 2013 Abstract: The Paeonia root, with or without bark, are considered vital traditional Chinese medicine materials; the examples are those of Bai Shao, Chi Shao, and Dan Pi. In this study, we examine 24 genes and their expressions involved in the biosynthesis of paeoniflorin and its derivatives, which are active compounds of the Paeonia root, in Paeonia lactiflora and P. suffruticosa, as well as other related plants, Punica granatum, Rhus radicans, and Coriaria nepalensis. Our phylogenetic analyses suggest that these genes have functional diversity, and analysis of the transcriptional level shows paeoniflorin and gallic acid biosynthesis-related genes exhibit different transcription profiles in flowers, carpels, bark-free roots, and bark of P. -
Colonic Metabolism of Phenolic Compounds: from in Vitro to in Vivo Approaches Juana Mosele
Nom/Logotip de la Universitat on s’ha llegit la tesi Colonic metabolism of phenolic compounds: from in vitro to in vivo approaches Juana Mosele http://hdl.handle.net/10803/378039 ADVERTIMENT. L'accés als continguts d'aquesta tesi doctoral i la seva utilització ha de respectar els drets de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials d'investigació i docència en els termes establerts a l'art. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix l'autorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No s'autoritza la seva reproducció o altres formes d'explotació efectuades amb finalitats de lucre ni la seva comunicació pública des d'un lloc aliè al servei TDX. Tampoc s'autoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs. ADVERTENCIA. El acceso a los contenidos de esta tesis doctoral y su utilización debe respetar los derechos de la persona autora. Puede ser utilizada para consulta o estudio personal, así como en actividades o materiales de investigación y docencia en los términos establecidos en el art. 32 del Texto Refundido de la Ley de Propiedad Intelectual (RDL 1/1996). Para otros usos se requiere la autorización previa y expresa de la persona autora. -
WO 2018/002916 Al O
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL). -
Total Synthesis of C-Arylglucosidic Ellagitannins
Università degli Studi di Ferrara DOTTORATO DI RICERCA IN CoTUTELA con l’UNIVERSITA’ DI BORDEAUX I in Scienze Farmaceutiche CICLO XXII COORDINATORE Prof. Stefano Manfredini Towards the first total synthesis of C-arylglucosidic ellagitannins. A biomimetic approach. Settore Scientifico Disciplinare CHIM/09 Sostenuto il 6 Aprile 2010 In seguito alla valutazione di: Piero PUCCI Professore, Università di Napoli Controrelatore Alessandro PEZZELLA Ricercatore, Università di Napoli Controrelatore Stefan CHAISSANG Ricercatore, Université de Toulouse Referee Doctor Europeus Piet HERDEWIJN Professore, Università di Leuven Referee Doctor Europeus Davanti alla commissione costituita da: Piero PUCCI Professore, Università di Napoli Presidente della Commissione Alessandro PEZZELLA Ricercatore, Università di Napoli Esaminatore Stéphane QUIDEAU Professore, Università di Bordeaux Correlatore di tesi Stefano MANFREDINI Professore, Università di Ferrara Relatore di tesi Stefan CHAISSANG Ricercatore, Université de Toulouse Esaminatore Dottorando Tutore Dott. Natangelo Anna Prof. Manfredini Stefano _______________________________ _____________________________ (firma) (firma) Prof. Quideau Stéphane _____________________________ (firma) Anni 2007/2010 N° d’ordre : 4019 THÈSE en Co-Tutelle PRÉSENTÉE A L’UNIVERSITÉ BORDEAUX 1 ÉCOLE DOCTORALE DES SCIENCES CHIMIQUES par Anna Natangelo POUR OBTENIR LE GRADE DE DOCTEUR SPÉCIALITÉ : CHIMIE ORGANIQUE Vers la première synthèse totale d’ellagitannins C-arylglucosidiques. Une approche biomimétique. Directeur de thèse : -
Current Trends in the Research of Emblica Officinalis (Amla): a Pharmacological Perspective
Int. J. Pharm. Sci. Rev. Res., 24(2), Jan – Feb 2014; nᵒ 25, 150-159 ISSN 0976 – 044X Review Article Current Trends in the Research of Emblica officinalis (Amla): A Pharmacological Perspective Swetha Dasaroju*, Krishna Mohan Gottumukkala Centre for Pharmaceutical Sciences (CPS), Institute of Science and Technology (IST), Jawaharlal Nehru Technological University – Hyderabad (JNTUH), Andhra Pradesh, India. *Corresponding author’s E-mail: [email protected] Accepted on: 20-11-2013; Finalized on: 31-01-2014. ABSTRACT Phyllanthus emblica Linn. Or Emblica officinalis Gaertn. commonly known as Indian gooseberry or Amla is one of the most important medicinal plants in Indian traditional systems of medicine (Ayurveda, Unani and Siddha). It is a well-known fact that all parts of amla are useful in the treatment of various diseases. Among all, the most important part is fruit. Amla fruit is widely used in the Indian system of medicine as diuretic, laxative, liver tonic, refrigerant, stomachic, restorative, anti-pyretic, hair tonic, ulcer preventive and for common cold, fever; as alone or in combination with other plants. Phytochemical studies on amla disclosed major chemical constituents including tannins, alkaloids, polyphenols, vitamins and minerals. Gallic acid, ellagic acid, emblicanin A & B, phyllembein, quercetin and ascorbic acid are found to be biologically effective. Research reports on amla reveals its analgesic, anti-tussive, anti- atherogenic, adaptogenic; cardio, gastro, nephro and neuroprotective, chemopreventive, radio and chemo modulatory and anti- cancer properties. Amla is also reported to possess potent free radical scavenging, antioxidant, anti-inflammatory, anti-mutagenic, immunomodulatory activities, which are efficacious in the prevention and treatment of various diseases like cancer, atherosclerosis, diabetes, liver and heart diseases. -
Chemical Composition, Antioxidant and Hepatoprotective Activities of Methanol Extracts from Leaves of Terminalia Bellirica and Terminalia Sericea (Combretaceae)
Chemical composition, antioxidant and hepatoprotective activities of methanol extracts from leaves of Terminalia bellirica and Terminalia sericea (Combretaceae) Mansour Sobeh1, Mona F. Mahmoud2, Rehab A. Hasan3, Mohamed A.O. Abdelfattah4, Samir Osman5, Harun-or Rashid6, Assem M. El-Shazly7 and Michael Wink1 1 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt 3 Department of Histology, Faculty of Medicine for Girls, Al Azhar University, Cairo, Egypt 4 Department of Science, College of Engineering and Technology, American University of the Middle East, Kuwait 5 Department of Pharmacognosy, Faculty of Pharmacy, October 6 University, Cairo, Egypt 6 Biotechnology Division, Bangladesh Institute of Nuclear Agriculture Bangladesh, Mymensingh, Bangladesh 7 Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt ABSTRACT Background: Plants belonging to the genus Terminalia such as Terminalia bellirica and Terminalia sericea are used traditionally to treat several diseases and health disorders. Up to this date, the roots of Terminalia sericea and the fruits of Terminalia bellirica are the mostly studied plant parts. The phytochemical composition and the biological activities of the leaves of both species are not well identified so far. Methods: The secondary metabolites of Terminalia bellirica and Terminalia sericea fi Submitted 3 October 2018 leaves were identi ed using HPLC-PDA-MS/MS. The antioxidant activities of Accepted 20 December 2018 the leaves extracts were determined by DPPH and FRAP assays. Published 27 February 2019 The hepatoprotective potential was evaluated in rats with D-galactosamine induced Corresponding authors liver damage. The effect of the extracts on the expression of the anti-apoptotic marker Mansour Sobeh, Bcl-2 was measured in an immunohistochemical study. -
Pomegranate: Constituents, Bioactivities and Pharmacokinetics
® Fruit, Vegetable and Cereal Science and Biotechnology ©2010 Global Science Books Pomegranate: Constituents, Bioactivities and Pharmacokinetics Rufeng Wang1,2 • Yi Ding2 • Ruining Liu3 • Lan Xiang4 • Lijun Du2* 1 School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China 2 Laboratory of Pharmaceutical Sciences, School of Life Sciences and School of Medicine, Tsinghua University, Beijing 100084, China 3 Department of Pharmacy, First Teaching Hospital of Tsinghua University, Beijing 100016, China 4 School of Pharmacy, Shandong University, Jinan 250012, China Corresponding author : * [email protected] ABSTRACT Pomegranate (Punica granatum L.), a species of Punicaceae, has recently become of great interest to the scientists who engage themselves in pharmaceutical, nutriological and pharmacological research, and new drug development, due to its distinctive multiple officinal parts and multiple bioactivities such as hypolipidemic, antioxidant, antiviral, anti-neoplastic, antibacterial, anti-diabetic, anti- diarrheal, and helminthic effects. In the present review, we reported the research on pomegranate as to chemical constituents, bioactivities and pharmacokinetics in combination with the recent publications. The constituents of this plant were thoroughly reviewed, and the biosynthetic pathways of major compounds were discussed based on our research results and those reported in the literatures. The bioactivities categorized by vascular protection, digestive protection, anti-pathogenic microbes, anticancer, -
The Antimicrobial Capacity of Cistus Salviifolius and Punica Granatum
www.nature.com/scientificreports OPEN The antimicrobial capacity of Cistus salviifolius and Punica granatum plant extracts against clinical pathogens is related to their polyphenolic composition Francisco Javier Álvarez‑Martínez1, Juan Carlos Rodríguez2, Fernando Borrás‑Rocher3, Enrique Barrajón‑Catalán1,5* & Vicente Micol1,4,5 Antimicrobial resistance poses a serious threat to human health worldwide. Plant compounds may help to overcome antibiotic resistance due to their potential resistance modifying capacity. Several botanical extracts and pure polyphenolic compounds were screened against a panel of eleven bacterial isolates with clinical relevance. The two best performing agents, Cistus salviifolius (CS) and Punica granatum (GP) extracts, were tested against 100 Staphylococcus aureus clinical isolates, which resulted in average MIC50 values ranging between 50–80 µg/mL. CS extract, containing hydrolyzable tannins and favonoids such as myricetin and quercetin derivatives, demonstrated higher activity against methicillin‑resistant S. aureus isolates. GP extract, which contained mostly hydrolyzable tannins, such as punicalin and punicalagin, was more efective against methicillin‑sensitive S. aureus isolates. Generalized linear model regression and multiple correspondence statistical analysis revealed a correlation between a higher susceptibility to CS extract with bacterial resistance to beta‑lactam antibiotics and quinolones. On the contrary, susceptibility to GP extract was related with bacteria sensitive to quinolones and oxacillin. Bacterial susceptibility to GP and CS extracts was linked to a resistance profle based on cell wall disruption mechanism. In conclusion, a diferential antibacterial activity against S. aureus isolates was observed depending on antibiotic resistance profle of isolates and extract polyphenolic composition, which may lead to development of combinatorial therapies including antibiotics and botanical extracts.